I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bethge, Wolfgang
236
results:
english X
Search for persons
X
Format
Online (236)
Mediatypes
E-Books (3)
Articles (Online) (113)
OpenAccess-fulltext (120)
Sorted by: Relevance
Sorted by: Year
?
1
An aggressive mediastinal EBV‐associated large B cell lymph..:
Kurz, Katrin S
;
Noerenberg, Daniel
;
Schaich, Markus
...
Histopathology. 85 (2024) 1 - p. 195-197 , 2024
Link:
https://doi.org/10.1111/..
?
2
Case report: Sequential inotuzumab, blinatumomab, and chemo..:
Beer, Sina A.
;
Bethge, Wolfgang
;
Faul, Christoph
..
eJHaem. 5 (2024) 3 - p. 620-623 , 2024
Link:
https://doi.org/10.1002/..
?
3
Fludarabine-treosulfan versus fludarabine-melphalan or busu..:
Beelen, Dietrich Wilhelm
;
Iacobelli, Simona
;
Koster, Linda
...
Bone Marrow Transplantation. 59 (2024) 5 - p. 670-679 , 2024
Link:
https://doi.org/10.1038/..
?
4
Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapse..:
Gagelmann, Nico
;
Bishop, Michael
;
Ayuk, Francis
...
Transplantation and Cellular Therapy. 30 (2024) 6 - p. 584.e1-584.e13 , 2024
Link:
https://doi.org/10.1016/..
?
5
Allogeneic hematopoietic cell transplantation for older pat..:
Maffini, Enrico
;
Labopin, Myriam
;
Kröger, Nicolaus
...
Bone Marrow Transplantation. 59 (2024) 7 - p. 983-990 , 2024
Link:
https://doi.org/10.1038/..
?
6
Allogeneic hematopoietic cell transplantation for adult met..:
Riedel, Andreas
;
Faul, Christoph
;
Reuss, Kristina
...
Blood Advances. 8 (2024) 6 - p. 1504-1508 , 2024
Link:
https://doi.org/10.1182/..
?
7
Adenovirus‐ and cytomegalovirus‐specific adoptive T‐cell th..:
Obermaier, Benedikt
;
Braun, Christiane
;
Hensen, Luca
...
Transplant Infectious Disease. , 2024
Link:
https://doi.org/10.1111/..
?
8
Applying the EHA/EBMT grading for ICAHT after CAR-T: compar..:
Rejeski, Kai
;
Wang, Yucai
;
Hansen, Doris K.
...
Blood Advances. 8 (2024) 8 - p. 1857-1868 , 2024
Link:
https://doi.org/10.1182/..
?
9
Management of Patients Undergoing CAR-T Cell Therapy in Ger..:
Penack, Olaf
;
Dreger, Peter
;
Ajib, Salem
...
Oncology Research and Treatment. 47 (2024) 3 - p. 65-75 , 2024
Link:
https://doi.org/10.1159/..
?
10
Remission induction versus immediate allogeneic haematopoie..:
Stelljes, Matthias
;
Middeke, Jan Moritz
;
Bug, Gesine
...
The Lancet Haematology. 11 (2024) 5 - p. e324-e335 , 2024
Link:
https://doi.org/10.1016/..
?
11
Impact of busulfan versus treosulfan dose intensity in myel..:
Gagelmann, Nico
;
Schuh, Claudia
;
Flossdorf, Sarah
...
American Journal of Hematology. 99 (2024) 8 - p. 1540-1549 , 2024
Link:
https://doi.org/10.1002/..
?
12
Reduced intensity versus myeloablative conditioning for MDS..:
Niederwieser, Christian
;
Iacobelli, Simona
;
Franke, Georg-Nikolaus
...
Bone Marrow Transplantation. , 2024
Link:
https://doi.org/10.1038/..
?
13
Outcomes of axicabtagene ciloleucel in PMBCL compare favora..:
Schubert, Maria-Luisa
;
Bethge, Wolfgang A.
;
Ayuk, Francis A.
...
Blood Advances. 7 (2023) 20 - p. 6191-6195 , 2023
Link:
https://doi.org/10.1182/..
?
14
Total body irradiation versus busulfan based intermediate i..:
Hirschbühl, Klaus
;
Labopin, Myriam
;
Polge, Emmanuelle
...
Bone Marrow Transplantation. 58 (2023) 8 - p. 874-880 , 2023
Link:
https://doi.org/10.1038/..
?
15
P352: PROPHYLACTIC AND PREEMPTIVE USE OF DLI COMPARE FAVOUR..:
Haupt, Maik
;
Jäkel, Nadja
;
Wachsmuth, Maria
...
HemaSphere. 7 (2023) S3 - p. e85305e4 , 2023
Link:
https://doi.org/10.1097/..
1-15